Best Healthcare Stocks - Intuitive Surgical, Inc. (NASDAQ:ISRG), Geron Corporation (NASDAQ:GERN), Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB)

New York, NY -- (SBWIRE) -- 03/19/2013 -- StockRunway.com issues special report on the Best Healthcare Stocks – Intuitive Surgical, Inc. (NASDAQ:ISRG), Geron Corporation (NASDAQ:GERN), Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB).

Intuitive Surgical, Inc.(NASDAQ:ISRG) surged +5.68% and closed at $485.52 in the last trading session with the total traded volume of 1.18 million shares. That’s more than the average volume of 512,814. The stock bounced back after a group of surgeons came to defend the company’s robotic devices and an analyst raised the pricey stock afterward. Canaccord Genuity’s Jason Mills lifted the stock to a buy rating and a PT at $527 a share.

ISRG is now trading above its 50 day moving average of -10.33% and 200 day moving average of -7.41%. It has outstanding shares of 40.38 million with the total market cap of $19.61 billion and its beta value stands at 1.57 times which shows that stock is more volatile.

Can ISRG Show a Strong Recovery? Find out in This Research Report

Geron Corporation (NASDAQ:GERN) added 5.31% with the closing price of $1.19, trimming declines it faced after reporting disappointing results, and even though its losses declined. The overall volume in the last trading session was 1.16 million shares. Its fifty two week range was $0.91-$2.99. The total market capitalization remained $155.60million.

GERN is ahead its 52 week low with 30.77% and its last month price volatility remained 5.75%. Its beta coefficient was 0.98 with a target price of $1.50. In its share capital, the company has 130.76million outstanding shares while 128.61million shares have been floated in market. It has insider ownership of 0.96% with its institutional ownership remained 31.51%. EPS this year advanced 31.83%.

Should GERN a Buy or Sell Now? Find Out Here

Navidea Biopharmaceuticals Inc(NYSEAMEX:NAVB) increased +4.12% to close at $2.78 in the last trading session and its total traded volume was 3.62 million shares, beating the average volume of 1.67 million. The $298.55M company recently filed Form 8-K with the SEC.

It has earnings per share of -$0.31, net profit margin of -40989.89% and operating margin of -41714.80%. The stock has negative year-to-date performance of -1.77% and is trading above its 50 day moving average of -10.10% and 200 day moving average of -12.33%.

What NAVB’s Charts Are Signaling for Traders? Find Out Here

About StockRunway.com
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.

Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!

Disclaimer
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.

Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/